Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24.75 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $24.75 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $24.75 | 1 | Regeneron Healthcare Solutions, Inc. ($24.75) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2017 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 248 | 498 | $242,763 | $83,301 |
| 2021 | 9 | 467 | 1,068 | $486,107 | $176,815 |
| 2020 | 8 | 460 | 890 | $266,618 | $105,281 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 13 | 82 | $205,000 | $58,816 | 28.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 88 | 117 | $18,334 | $11,434 | 62.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 13 | 42 | $7,181 | $4,426 | 61.6% |
| 92134 | Imaging of retina | Office | 2022 | 37 | 105 | $5,187 | $3,719 | 71.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 14 | 40 | $4,350 | $3,340 | 76.8% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 62 | 91 | $2,091 | $1,174 | 56.1% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 21 | 21 | $620.83 | $392.32 | 63.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 16 | 164 | $410,000 | $119,897 | 29.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 136 | 218 | $32,555 | $23,772 | 73.0% |
| 67028 | Injection of drug into eye | Office | 2021 | 16 | 86 | $11,551 | $9,384 | 81.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 83 | 243 | $12,628 | $9,092 | 72.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 24 | 95 | $10,111 | $7,972 | 78.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 20 | 20 | $3,585 | $2,586 | 72.1% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 100 | 165 | $3,120 | $2,275 | 72.9% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 59 | 63 | $1,908 | $1,312 | 68.8% |
| 92250 | Photography of the retina | Office | 2021 | 13 | 14 | $649.32 | $524.98 | 80.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 14 | 80 | $200,000 | $58,671 | 29.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 140 | 186 | $27,461 | $18,711 | 68.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 32 | 102 | $10,762 | $8,109 | 75.4% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 78 | 207 | $11,895 | $7,491 | 63.0% |
| 67028 | Injection of drug into eye | Office | 2020 | 16 | 76 | $8,996 | $7,274 | 80.9% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2020 | 80 | 99 | $2,968 | $2,088 | 70.4% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2020 | 88 | 128 | $2,448 | $1,707 | 69.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 12 | 12 | $2,088 | $1,229 | 58.8% |
About Dr. Niel Squillante, M.D
Dr. Niel Squillante, M.D is a Retina Specialist healthcare provider based in Bedford, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790877603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niel Squillante, M.D has received a total of $24.75 in payments from pharmaceutical and medical device companies, with $24.75 received in 2017. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($24.75).
As a Medicare-enrolled provider, Squillante has provided services to 1,175 Medicare beneficiaries, totaling 2,456 services with total Medicare billing of $365,397. Data is available for 3 years (2020–2022), covering 24 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Bedford, NY
- Active Since 09/28/2006
- Last Updated 10/24/2022
- Taxonomy Code 207WX0107X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790877603
Products in Payments
- EYLEA AFLIBERCEPT INJECTION (Biological) $24.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.